VeriMom¿Es garcinia hanburyi sap powder seguro durante el embarazo?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments specific to 'Garcinia hanburyi sap powder' were identified. Peer‑reviewed literature shows bioactive cytotoxic constituents (e.g., gambogic acid) but no conclusive reproductive/developmental data for topical use; therefore default hazard and mechanism scores are 0. Low but potentially measurable dermal absorption is assumed for small lipophilic xanthonoids so exposure scored 1 for pregnancy. Sources checked: ECHA Annex VI (no harmonised CLP), CIR (no assessment found), PubChem/PubMed on gambogic acid (bioactivity but no reproductive classification).
Related ingredients
Frequently asked questions
- ¿Es garcinia hanburyi sap powder seguro durante el embarazo?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments specific to 'Garcinia hanburyi sap powder' were identified. Peer‑reviewed literature shows bioactive cytotoxic constituents (e.g., gambogic acid) but no conclusive reproductive/developmental data for topical use; therefore default hazard and mechanism scores are 0. Low but potentially measurable dermal absorption is assumed for small lipophilic xanthonoids so exposure scored 1 for pregnancy. Sources checked: ECHA Annex VI (no harmonised CLP), CIR (no assessment found), PubChem/PubMed on gambogic acid (bioactivity but no reproductive classification).
- ¿Es garcinia hanburyi sap powder seguro durante la lactancia?
- No specific data indicating reproductive or lactation-related toxicity or harmonised classification. Potential for low dermal absorption of small bioactive constituents suggests low but measurable maternal exposure and theoretical transfer into milk cannot be excluded, so exposure scored 1. No direct evidence of breastmilk transfer or infant effects in prioritized sources (ECHA Annex VI, CIR, PubMed, PubChem).
- ¿Es garcinia hanburyi sap powder seguro para la piel del bebé?
- No infant‑specific reproductive or developmental data were found. Because the ingredient contains small lipophilic xanthonoids (e.g., gambogic acid) that could be dermally absorbed, infant exposure score is increased by +1 from adult exposure (adult e=1 → baby e=2) to reflect immature barrier and higher surface‑area‑to‑weight ratio. No data were found to justify increasing hazard or mechanism scores for infants.
- ¿Cómo puntúa VeriMom a garcinia hanburyi sap powder?
- VeriMom puntúa garcinia hanburyi sap powder en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a garcinia hanburyi sap powder en el embarazo?
- Consulta nuestra lista de alternativas seguras a garcinia hanburyi sap powder según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.